» Articles » PMID: 33599248

Bc-GenExMiner 4.5: New Mining Module Computes Breast Cancer Differential Gene Expression Analyses

Overview
Specialty Biology
Date 2021 Feb 18
PMID 33599248
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

'Breast cancer gene-expression miner' (bc-GenExMiner) is a breast cancer-associated web portal (http://bcgenex.ico.unicancer.fr). Here, we describe the development of a new statistical mining module, which permits several differential gene expression analyses, i.e. 'Expression' module. Sixty-two breast cancer cohorts and one healthy breast cohort with their corresponding clinicopathological information are included in bc-GenExMiner v4.5 version. Analyses are based on microarray or RNAseq transcriptomic data. Thirty-nine differential gene expression analyses, grouped into 13 categories, according to clinicopathological and molecular characteristics ('Targeted' and 'Exhaustive') and gene expression ('Customized'), have been developed. Output results are visualized in four forms of plots. This new statistical mining module offers, among other things, the possibility to compare gene expression in healthy (cancer-free), tumour-adjacent and tumour tissues at once and in three triple-negative breast cancer subtypes (i.e. C1: molecular apocrine tumours; C2: basal-like tumours infiltrated by immune suppressive cells and C3: basal-like tumours triggering an ineffective immune response). Several validation tests showed that bioinformatics process did not alter the pathobiological information contained in the source data. In this work, we developed and demonstrated that bc-GenExMiner 'Expression' module can be used for exploratory and validation purposes. Database URL: http://bcgenex.ico.unicancer.fr.

Citing Articles

A comprehensive bioinformatic evaluation of the NTRK family's potential as prognostic biomarkers in breast cancer.

Mohammadi R, Ghiasi M, Mehdizadeh S, Mohammadi J, Mohammad Ganji S Bioinform Adv. 2025; 5(1):vbaf030.

PMID: 40061872 PMC: 11886811. DOI: 10.1093/bioadv/vbaf030.


Profile and clinical significance of SPARCL1 and its prognostic significance in breast cancer.

Xu X, Han Y, Song Y, Zhou Z, Chen S, Liu Y Oncol Lett. 2025; 29(4):196.

PMID: 40046638 PMC: 11880884. DOI: 10.3892/ol.2025.14942.


Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment.

Wang T, Lei Y, Sun J, Wang L, Lin Y, Wu Z Front Oncol. 2025; 14:1536406.

PMID: 39927118 PMC: 11802438. DOI: 10.3389/fonc.2024.1536406.


The Multifaceted Roles of Myrrha in the Treatment of Breast Cancer: Potential Therapeutic Targets and Promises.

Shams A, Alzahrani A, Ayash T, Tamur S, Al-Mourgi M Integr Cancer Ther. 2024; 23:15347354241309659.

PMID: 39707884 PMC: 11663268. DOI: 10.1177/15347354241309659.


LUCAT1-Mediated Competing Endogenous RNA (ceRNA) Network in Triple-Negative Breast Cancer.

Verma D, Siddharth S, Yende A, Wu Q, Sharma D Cells. 2024; 13(22).

PMID: 39594666 PMC: 11593075. DOI: 10.3390/cells13221918.


References
1.
Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

2.
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100(14):8418-23. PMC: 166244. DOI: 10.1073/pnas.0932692100. View

3.
Rooney M, Shukla S, Wu C, Getz G, Hacohen N . Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015; 160(1-2):48-61. PMC: 4856474. DOI: 10.1016/j.cell.2014.12.033. View

4.
Burstein M, Tsimelzon A, Poage G, Covington K, Contreras A, Fuqua S . Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2014; 21(7):1688-98. PMC: 4362882. DOI: 10.1158/1078-0432.CCR-14-0432. View

5.
Jezequel P, Frenel J, Campion L, Guerin-Charbonnel C, Gouraud W, Ricolleau G . bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses. Database (Oxford). 2013; 2013:bas060. PMC: 3548333. DOI: 10.1093/database/bas060. View